Accurate isoform discovery with IsoQuant using long reads.

Prjibelski AD, Mikheenko A, Joglekar A, Smetanin A, Jarroux J, Lapidus AL, Tilgner HU. · 2023

Read Accurate isoform discovery with IsoQuant using long reads. by Prjibelski AD, Mikheenko A, Joglekar A, Smetanin A, Jarroux J, Lapidus AL, Tilgner HU. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10344776.txt.

Introduction

Prjibelski and colleagues built IsoQuant in 2023, a tool for long-read RNA data. RNA carries gene messages out of DNA, and one gene can make many message forms. Long reads can span a full message, but errors make the forms hard to rebuild. IsoQuant maps the reads to a genome and traces the joins between gene parts.

The tool works with or without a known gene list. Prjibelski found that it cut false finds fivefold when a gene list was used. In free mode, with no list, false finds fell by a factor of 2.5. It links splice joins, the cut points in a message, into a graph. Paths through that graph give the full message forms and their counts.

Catalog record

CREATORPrjibelski AD, Mikheenko A, Joglekar A, Smetanin A, Jarroux J, Lapidus AL, Tilgner HU.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10344776

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Accurate isoform discovery with IsoQuant using long reads By Andrey D. Prjibelski, Alla Mikheenko, Anoushka Joglekar, Alexander Smetanin, Julien Jarroux, Alla L. Lapidus, Hagen U. Tilgner Published in: Nature Biotechnology DOI: 10.1038/s41587-022-01565-y ABSTRACT Annotating newly sequenced genomes and determining alternative isoforms from long-read RNA data are complex and incompletely solved problems. Here we present IsoQuant—a computational tool using intron graphs that accurately reconstructs transcripts both with and without reference genome annotation. For novel transcript discovery, IsoQuant reduces the false-positive rate fivefold and 2.5-fold for Oxford Nanopore reference-based or reference-free mode, respectively. IsoQuant also improves performance for Pacific Biosciences data. MAIN Long-read RNA sequencing is now widely used in bulk, sorted cells, single cells and spatial approaches. This wide field of applications has led to the development of multiple spliced alignment programs1–4, transcript discovery methods5–11, tools for transcript classification12, annotation13 and visualization14,15. Additionally, several reference-free tools for RNA long-read correction and assembly have been developed16,17. Current community efforts address the problem of understanding performance, weaknesses and advantages of each approach for various applications18. Here we present IsoQuant—a tool for transcript discovery and quantification with long RNA reads. IsoQuant takes as input a reference genome and a dataset containing PacBio or ONT (Oxford Nanopore Technologies) RNA reads. By default, IsoQuant maps input reads to the genome via minimap2 in splice mode2. Alternatively, a user may provide BAM files generated with a spliced aligner of their choice, for example STARlong1 for PacBio and uLTRA4 or deSALT3 for ONT reads. In two distinct modes, IsoQuant can be used for de novo annotation-free transcript discovery as well as with the reference gene annotation. IsoQuant uses long-read spliced alignments to construct an intron graph, in which vertices are splice junctions, that is, pairs of splice sites (donor and acceptor), and two vertices are connected with a directed edge if the corresponding splice junctions are consecutive in at least one read (Methods). This graph is exploited for constructing paths that correspond to full-length transcripts (Fig. 1a). If the reference annotation is provided, IsoQuant first assigns reads to known isoforms via an inexact intron-chain matching algorithm that accounts for splice site shifts, which are typical for alignment of error-prone reads19. These assignments are further used for reference transcript quantification and correction of inaccurately detected splice junctions and misalignments, such as skipped microexons.Fig. 1IsoQuant pipeline outline and characteristics of novel transcripts generated from mouse simulated data.a, Outline of the IsoQuant pipeline. When a reference gene annotation is provided, reads are assigned to annotated isoforms and alignment artifacts are corrected (top). The intron graph is constructed from read alignments (middle) and transcripts are discovered via path construction (bottom). b, F1-score for novel transcripts reported by different tools on simulated ONT (left) and PacBio data (right). c, Precision and recall for novel transcripts reported by different tools on simulated ONT data broken up by expression levels in TPM. TPM bins are presented by dot sizes. d, Precision (left) and recall (right) for novel transcripts reported by different tools on simulated ONT data. e, Same as d, but for simulated PacBio data.Source Data To compare IsoQuant performance against existing transcript discovery tools, we first simulated mouse PacBio and ONT data using realistic gene expression profiles with IsoSeqSim (https://github.com/yunhaowang/IsoSeqSim) and Trans-NanoSim20 respectively. For more informative benchmarking, we simulated an ONT R9.4 dataset representing R9.4 chemistry and an ONT R10.4 dataset corresponding to a more accurate R10.4 chemistry (Methods). To mimic real-life datasets containing unannotated transcripts, we arbitrarily removed 5,311 (15%) of 35,684 expressed isoforms (the ones contributing to at least one read during the simulation) from the GENCODE21 gene annotation. These 5,311 hidden transcripts were further used as a ground truth for novel transcript discovery. The reduced GENCODE annotation was used as an input for all tools. Each output annotation was then separated into a set of known and a set of novel transcripts, which were compared against the respective baselines using gffcompare22 (Methods). For known transcripts, IsoQuant has the highest F1-score (the harmonic mean of precision and recall) compared to TALON7, FLAIR8, Bambu11 and StringTie5, but these advances are not dramatic (Supplementary Tables 1–3). However, IsoQuant produces novel transcripts with a 1.9-fold higher F1-score on ONT R10.4 data compared to the second-best tool, StringTie. In comparison to TALON, FLAIR and Bambu, the improvement in F1-score is even more noticeable (Fig. 1b, left). On PacBio data, IsoQuant again shows the best F1-score, but the difference from other tools is smaller than for ONT R10.4 data (Fig. 1b, right). Compared to most tools, IsoQuant’s improvements in F1-score is primarily caused by its very high precision of novel transcripts. As compared to TALON, FLAIR and StringTie, IsoQuant shows a minimum of fivefold drop in false-positive rate on ONT R10.4 data, while still maintaining slight gains in recall (Fig. 1d). The situation is of a different nature for Bambu. IsoQuant has higher precision (86.3 versus 69.9%), but substantially higher recall: while Bambu only reconstructs 73 out of 5,311 novel isoforms (1% recall), IsoQuant reconstructs 3,848 (62.6%). On ONT R9.4 simulated data IsoQuant similarly shows a notably lower false-positive rate compared to other tools (Supplementary Table 2). On PacBio simulated data, similar trends can be observed for novel transcripts, although with a less drastic difference in specificity. Bambu shows slightly higher precision (95.8%) compared to IsoQuant (94.4%), but again has the lowest recall (18.7% for Bambu versus 76.8% for IsoQuant). StringTie, TALON and FLAIR again predict transcripts with comparable recall, but have at least fivefold higher false-positive rate compared to IsoQuant (Fig. 1e, detailed analysis of the false-positive transcript is provided in Supplementary Note 8). Further, we measured precision and recall for novel transcripts with different expression levels (Fig. 1c and Supplementary Fig. 1). While all tools tend to show lower recall and precision for lowly expressed transcripts, IsoQuant yields highly specific transcript models (≥80% precision) and maintains advances for novel transcript discovery regardless of the expression levels. Thus, IsoQuant is likely to be highly useful across many genes, including but not limited to low-expressed long-noncoding RNAs and marker genes of cell types. Among the five listed methods, only StringTie and IsoQuant support annotation-free transcript discovery. Thus, we compared these two tools on the same simulated datasets used above without providing any annotation (Supplementary Table 4). On PacBio data both tools yield highly accurate transcript models. On ONT data StringTie shows higher recall, while IsoQuant generates transcripts with substantially lower false-positive rates (2.5-fold decrease for ONT R10.4 dataset and 3.7-fold for ONT R9.4). While overall quality of transcripts discovered in reference-based mode is, indeed, higher compared to annotation-free runs, the precision and recall of novel transcripts appears to be rather similar in both modes. To complement our benchmarks on simulated data, we also sequenced Lexogen spike-in RNA variant (SIRV) synthetic molecules on the Oxford Nanopore MinION using ONT R10.4 flowcells (Methods). Along with the complete SIRV annotation, Lexogen provides an incomplete annotation, missing 26 out of the total 69 SIRV isoforms, which allows the evaluation of novel transcript discovery, similar to the one we performed for simulated data with the reduced GENCODE annotation. Results on SIRV sequencing data resemble the ones obtained on simulated reads. When predicting novel isoforms, IsoQuant shows at least four times higher F1-score

Read the complete text